CLINICAL_TRIALS
trial_result
· 2018-04-12
Clinical Trial Update: Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber [Phase 1]
Summary
Phase 1 study evaluating innate neutrophilic nasal inflammation in allergic rhinitis using a pollen exposure chamber has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED